BENEFITS OF MERGER. 6.1 The benefits accruing from the merger of BPL with MPL would include:
BENEFITS OF MERGER. Both the Target and the Survivor agree to the following reasons and justifications for pursuing a Merger (the "Benefits" :) The Target has its common shares publicly traded on OTC Markets PINK, whilst the Survivor is a fully-reporting company with audited financials whose common stock also recently became listed on OTC Markets PINK. Both companies are specialized in the field of pharmaceuticals and at this point of time on the basis of a Cooperation Agreement are developing a joint business while splitting the funding and the net profit in equal 50% parts. To put in concrete terms, both of these companies will profit from the production and distribution of ITV-1, ITV-2, ITV-3, ITV-4, ITV-5 and TNG, which are drugs in injection form dedicated for the treatment of AIDS, chronic hepatitis S and C, rheumatoid arthritis, and other viral and infectious diseases, in which a strong cell immunity is of utmost importance. Both companies will also share the profits from 8 dietary supplements - Physiolong, Carotilen, Fructin, Dry Xxxx, Biodetoxin, Silymaron, Hypocholestin, and Anthocylen C. Exactly because of the joint structure of the business of both companies, a market extension merger between them would have a positive effect, which makes it the recommended and necessary choice of action. This is supported by the following additional circumstances: • Both companies have the same majority control shareholder, Xxxxxxx Xxxxxxxx Savov who is providing both with the necessary financing to cover their administrative and • development cost during the early stages of the companies; • The board of directors and the officers of both companies is comprised by the same individuals - specialists; • The merger will ease potential investors, as the Surviving Entity will own the entire business and there will be no confusion in which company to invest in; • The Merger will ease the marketing strategy of the Target and the Survivor and will help the dissemination to all useful information to investors and the public; • The Merger will ease the preparation of financial statements, the auditing, as well as any other mandatory disclosures to the regulatory bodies and the public; • The Merger will make it easier for investing in both the main properties - factory, laboratories for scientific research, etc. - as well as in the acquirement of new patents for medicines and dietary supplements, and their development and release on the market. • The Merger will decrease the operational cos...
